Longview Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$304M Sell
1,121,661
-133,088
-11% -$39.6M 4.3% 11
2025
Q4
$414M Sell
1,254,749
-67,126
-5% -$22.7M 4.33% 13
2025
Q3
$456M Buy
1,321,875
+105,793
+9% +$32M 4.77% 6
2025
Q2
$379M Buy
1,216,082
+278,350
+30% +$106M 3.27% 20
2025
Q1
$491M Sell
937,732
-58,130
-6% -$29.7M 3.95% 14
2024
Q4
$504M Sell
995,862
-42,336
-4% -$24.1M 3.76% 17
2024
Q3
$607M Buy
1,038,198
+7,220
+0.7% +$4.08M 4.16% 13
2024
Q2
$525M Sell
1,030,978
-137,810
-12% -$67.5M 3.9% 17
2024
Q1
$578M Sell
1,168,788
-22,820
-2% -$11.6M 3.73% 20
2023
Q4
$627M Sell
1,191,608
-96,730
-8% -$51.6M 4.19% 10
2023
Q3
$650M Buy
1,288,338
+3,271
+0.3% +$1.61M 4.6% 5
2023
Q2
$618M Buy
1,285,067
+153,840
+14% +$75.2M 4.05% 12
2023
Q1
$535M Buy
1,131,227
+164,255
+17% +$79.3M 3.77% 22
2022
Q4
$513M Buy
966,972
+16,190
+2% +$8.58M 4.07% 14
2022
Q3
$480M Sell
950,782
-240,377
-20% -$126M 4.12% 2
2022
Q2
$612M Sell
1,191,159
-518,826
-30% -$261M 4.68% 3
2022
Q1
$872M Sell
1,709,985
-63,817
-4% -$30.8M 5.71% 1
2021
Q4
$891M Sell
1,773,802
-122,362
-6% -$55.4M 5.69% 2
2021
Q3
$741M Sell
1,896,164
-329,038
-15% -$136M 4.67% 11
2021
Q2
$891M Sell
2,225,202
-209,170
-9% -$83.4M 4.89% 9
2021
Q1
$906M Sell
2,434,372
-425,374
-15% -$147M 4.81% 5
2020
Q4
$1B Sell
2,859,746
-672,065
-19% -$225M 4.87% 8
2020
Q3
$1.1B Sell
3,531,811
-4,023
-0.1% -$1.24M 5.18% 8
2020
Q2
$1.04B Sell
3,535,834
-188,370
-5% -$54M 4.95% 7
2020
Q1
$929M Sell
3,724,204
-37,260
-1% -$10.3M 5% 8
2019
Q4
$1.11B Buy
3,761,464
+2,684
+0.1% +$702K 4.63% 14
2019
Q3
$817M Buy
3,758,780
+6,150
+0.2% +$1.48M 3.8% 16
2019
Q2
$916M Buy
3,752,630
+338,097
+10% +$81.3M 4.44% 15
2019
Q1
$844M Sell
3,414,533
-130,322
-4% -$33.2M 4.45% 15
2018
Q4
$883M Sell
3,544,855
-471,063
-12% -$124M 4.7% 9
2018
Q3
$1.07B Sell
4,015,918
-56,180
-1% -$14.6M 5.27% 7
2018
Q2
$999M Sell
4,072,098
-56,812
-1% -$13.6M 5.2% 4
2018
Q1
$884M Sell
4,128,910
-615,545
-13% -$141M 4.63% 14
2017
Q4
$1.05B Buy
4,744,455
+19,610
+0.4% +$4.16M 5.48% 6
2017
Q3
$925M Buy
4,724,845
+214,300
+5% +$41.4M 5% 5
2017
Q2
$836M Buy
4,510,545
+151,208
+3% +$26.5M 4.82% 5
2017
Q1
$715M Sell
4,359,337
-252,716
-5% -$41.4M 4.65% 10
2016
Q4
$738M Sell
4,612,053
-754,868
-14% -$113M 4.88% 4
2016
Q3
$751M Sell
5,366,921
-7,920
-0.1% -$1.11M 4.87% 5
2016
Q2
$759M Sell
5,374,841
-200,480
-4% -$26.7M 5.05% 3
2016
Q1
$719M Sell
5,575,321
-112,513
-2% -$13.3M 4.78% 5
2015
Q4
$669M Buy
5,687,834
+261,534
+5% +$30.6M 4.56% 10
2015
Q3
$630M Sell
5,426,300
-1,099,342
-17% -$132M 4.45% 12
2015
Q2
$796M Sell
6,525,642
-1,821,027
-22% -$215M 5.23% 3
2015
Q1
$987M Buy
8,346,669
+19,778
+0.2% +$2.2M 6.84% 1
2014
Q4
$842M Sell
8,326,891
-71,205
-0.8% -$6.75M 6.21% 3
2014
Q3
$724M Sell
8,398,096
-74,185
-0.9% -$6.27M 5.76% 6
2014
Q2
$693M Buy
8,472,281
+2,662,251
+46% +$209M 5.48% 11
2014
Q1
$476M Buy
+5,810,030
New +$437M 3.7% 18

Other funds holding UNH

Longview Partners's UNH Position: Q1 2026 in Review

Longview Partners reduced its UnitedHealth (UNH) stake by 11% in Q1 2026, selling an estimated $39.6M and leaving 1,121,661 shares worth $304M. The position accounts for 4.3% of the portfolio, ranked #11.

Longview Partners first reported a position in UNH in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.11B in Q4 2019. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Longview Partners held 1,121,661 shares of UnitedHealth worth $304M as of Q1 2026.
  • Longview Partners sold 133,088 UnitedHealth shares in Q1 2026, an estimated $39.6M.
  • UnitedHealth made up 4.3% of Longview Partners's portfolio in Q1 2026, its #11 holding.
  • Longview Partners first reported a position in UnitedHealth in Q1 2014 and has held it in 49 quarters since.
  • Longview Partners's UnitedHealth position peaked at $1.11B in Q4 2019.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Longview Partners's 13F filing for Q1 2026, filed 15 May 2026.